Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie Ma

Showing results (81-90 of 129) with videos related to

Pageof 13
Sort By:
Cell Chemical Biology|September 6, 2025
A covalent inhibitor targeting Cys16 on RhoA in colorectal cancerTin-Yan Koo, Jason Ying Ki Li, Nga-Sze Lee, et al.
Hepatology (Baltimore, Md.)|October 14, 2011
CD133(+) liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signalingKwan Ho Tang, Stephanie Ma, Terence K Lee, et al.
Science Translational Medicine|July 30, 2025
AGPAT4 targeted covalent inhibitor potentiates targeted therapy to overcome cancer cell plasticity in hepatocellular carcinoma mouse modelsKai-Yu Ng, Tin-Yan Koo, Ianto Bosheng Huang, et al.
Molecular Cancer|January 24, 2021
PARP inhibitor Olaparib overcomes Sorafenib resistance through reshaping the pluripotent transcriptome in hepatocellular carcinomaXiao-Dong Yang, Fan-En Kong, Ling Qi, et al.
Hepatology (Baltimore, Md.)|January 11, 2023
SERPINA12 promotes the tumorigenic capacity of HCC stem cells through hyperactivation of AKT/β-catenin signalingHuajian Yu, Lei Zhou, Jane H C Loong, et al.
The Journal of Clinical Investigation|February 3, 2011
An N-terminal truncated carboxypeptidase E splice isoform induces tumor growth and is a biomarker for predicting future metastasis in human cancersTerence K Lee, Saravana R K Murthy, Niamh X Cawley, et al.
Gastroenterology|June 19, 2012
Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinomaStephanie Ma, Jessie Y J Bao, Pak Shing Kwan, et al.
Cancer Research|February 28, 2018
IRAK1 Augments Cancer Stemness and Drug Resistance via the AP-1/AKR1B10 Signaling Cascade in Hepatocellular CarcinomaBowie Y Cheng, Eunice Y Lau, Hoi-Wing Leung, et al.
Carcinogenesis|January 21, 2016
PSCA acts as a tumor suppressor by facilitating the nuclear translocation of RB1CC1 in esophageal squamous cell carcinomaLi-Yi Zhang, Jian-Lin Wu, Hai-Bo Qiu, et al.
Cancer Research|September 9, 2017
FSTL1 Promotes Metastasis and Chemoresistance in Esophageal Squamous Cell Carcinoma through NFκB-BMP Signaling Cross-talkMarco Chi-Chung Lau, Kai Yu Ng, Tin Lok Wong, et al.
Pageof 13

Showing results (81-90 of 129) with videos related to

Sort By:
Pageof 13
Cell Chemical Biology|September 6, 2025
A covalent inhibitor targeting Cys16 on RhoA in colorectal cancerTin-Yan Koo, Jason Ying Ki Li, Nga-Sze Lee, et al.
Hepatology (Baltimore, Md.)|October 14, 2011
CD133(+) liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signalingKwan Ho Tang, Stephanie Ma, Terence K Lee, et al.
Science Translational Medicine|July 30, 2025
AGPAT4 targeted covalent inhibitor potentiates targeted therapy to overcome cancer cell plasticity in hepatocellular carcinoma mouse modelsKai-Yu Ng, Tin-Yan Koo, Ianto Bosheng Huang, et al.
Molecular Cancer|January 24, 2021
PARP inhibitor Olaparib overcomes Sorafenib resistance through reshaping the pluripotent transcriptome in hepatocellular carcinomaXiao-Dong Yang, Fan-En Kong, Ling Qi, et al.
Hepatology (Baltimore, Md.)|January 11, 2023
SERPINA12 promotes the tumorigenic capacity of HCC stem cells through hyperactivation of AKT/β-catenin signalingHuajian Yu, Lei Zhou, Jane H C Loong, et al.
The Journal of Clinical Investigation|February 3, 2011
An N-terminal truncated carboxypeptidase E splice isoform induces tumor growth and is a biomarker for predicting future metastasis in human cancersTerence K Lee, Saravana R K Murthy, Niamh X Cawley, et al.
Gastroenterology|June 19, 2012
Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinomaStephanie Ma, Jessie Y J Bao, Pak Shing Kwan, et al.
Cancer Research|February 28, 2018
IRAK1 Augments Cancer Stemness and Drug Resistance via the AP-1/AKR1B10 Signaling Cascade in Hepatocellular CarcinomaBowie Y Cheng, Eunice Y Lau, Hoi-Wing Leung, et al.
Carcinogenesis|January 21, 2016
PSCA acts as a tumor suppressor by facilitating the nuclear translocation of RB1CC1 in esophageal squamous cell carcinomaLi-Yi Zhang, Jian-Lin Wu, Hai-Bo Qiu, et al.
Cancer Research|September 9, 2017
FSTL1 Promotes Metastasis and Chemoresistance in Esophageal Squamous Cell Carcinoma through NFκB-BMP Signaling Cross-talkMarco Chi-Chung Lau, Kai Yu Ng, Tin Lok Wong, et al.
Pageof 13